Viktoriia Chernobrovina

Viktoriia Chernobrovina has extensive work experience in finance, with a focus on financial planning and analysis. Viktoriia is currently serving as the Director of Financial Planning and Analysis and Treasurer at Acorda Therapeutics, Inc. Prior to this, they worked as the Associate Director of Commercial Finance at Intercept Pharmaceuticals from 2020 to 2022. Viktoriia also held the position of Senior Finance Manager Global Operations Planning at Duracell (Berkshire Hathaway Company) from 2018 to 2019. Before that, they worked as the Commercial Finance Manager at Purdue Pharma L.P. from 2016 to 2018. Viktoriia started their career at PepsiCo in 2008, where they held various roles such as Senior Revenue Management Strategy Analyst, Senior Control Trade Investment Analyst, and Trade Spend Analyst. Viktoriia also worked as a Lead Finance Analyst - Commercial Finance at Diageo from 2014 to 2016.

Viktoriia Chernobrovina completed their Master of Business Administration (M.B.A.) with a focus on International Business and Finance at the University of Connecticut School of Business from 2013 to 2016. Prior to that, they attained their Master's Degree in Accounting and Audit at Kiev National Economic University from 2000 to 2005. Additionally, they have acquired several certifications including Biotechnology Management from Harvard University in January 2023, Vena Product Implementation Training from Vena Learning in February 2022, and Individual Income Tax Preparer from the Internal Revenue Service in January 2005.